Nanobiotix S.A.
Key Metrics
Market Snapshot
About
Nanobiotix S.A. is a French clinical-stage biotechnology company developing NBTXR3, a proprietary radioenhancer nanotechnology designed to amplify radiation therapy for cancer treatment. The company focuses on oncology applications across multiple tumor types.